Back to search

Article

<i>In vivo</i> generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearance

2025-04-24

Abstract excerpt

Despite striking efficacy against hematologic malignancies, the cost and complexity of CAR T manufacturing present significant barriers to broader patient access. Beyond manufacturing challenges, ex vivo expansion of T cells may be detrimental for their function and persistence. Thus, delivery of CARs to reprogram host cells in vivo would represent a significant advance toward “off-the-shelf” therapy but has bee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1e9c81e-73e8-5f22-a3c6-fe23296f5aeb
DOI
10.1101/2025.04.23.645810
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vivo</i> generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearanceDOI 10.1101/2025.04.23.645810
Select a neighboring publication to make it the new centre.